newsfilter
← Latest News
PR Newswire·

Medivir partners with world-leading liver cancer experts in new Scientific Advisory Council

STOCKHOLM, Aug. 7, 2023 /PRNewswire/ -- Medivir AB (NASDAQ:MVIR) (Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today the